Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair loss (androgenetic alopecia) mildly to moderately affects men's quality of life but not significantly their mental health.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Eclipta alba extract could be a promising natural treatment for hair loss.

New gene discoveries have improved diagnosis and treatment for skin and hair disorders, but more research is needed to fully understand them.

Forensic DNA Phenotyping accurately predicts physical traits and is used in investigations, but needs more diverse population data for confirmation.

PRP generally shows better results for hair regrowth than mesotherapy, but more research is needed.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

5α-reductase inhibitors are effective for treating hair loss in androgenetic alopecia.

Not all hair loss patients need lab tests; patient history and physical exams are key to deciding who does.

Male pattern baldness may be an early sign of noncancerous prostate enlargement.

The combination of Stemoxydine® and Resveratrol improves hair density in women with Female Pattern Hair Loss.

Early baldness in men may indicate a higher risk of prostate cancer.

Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

Minoxidil and finasteride are effective for male hair loss; minoxidil also helps female hair loss, with some treatments needing more research.

The issue discussed China's research contributions, systematic review improvements, and featured various medical studies and trials.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Iron deficiency is not more common in women with hair loss, and neurogenic rosacea may need different treatment.

Cataract surgery in Europe varies in frequency and cost between countries.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

The issue covers reproductive health topics like cancer markers, incontinence treatments, and the impact of pre-term birth.

Hair transplantation and micrografting are effective for cosmetic facial enhancement, requiring careful technique and postoperative care for successful outcomes.

Proper guidance on minoxidil use and side effects is crucial.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Dr. Dominic A. Brandy shared methods to fix aesthetic problems from old hair restoration techniques, using methods like follicular unit grafting and scalp removal, which helped patients look more natural after surgery. He also suggested using oral finasteride and topical minoxidil to control hair loss in most men with baldness, especially those who had flap surgery.

Hair loss was most commonly due to alopecia areata, androgenetic alopecia, and telogen effluvium, with a higher number of cases in the 1990s and equal occurrence in men and women.

Androgenetic alopecia is linked to family history and androgen effects.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

The document suggests improvements for a hair and scalp disease book and recommends a two-volume skin surgery reference for dermatologists.